Healthcare Success
JULY 5, 2022
(Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. Every time I run into someone who is faced with the daunting challenge of marketing to doctors or other healthcare professionals, I giggle empathetically and say, “I feel your pain.”. Get Your Doctors’ Attention Immediately.
pharmaphorum
JULY 6, 2022
He accepted the companies’ position that the painkillers they supplied – some 51 million between 2006 and 2014 – were shipped “in good faith” by the distributors before being prescribed by physicians and dispensed by pharmacies, and they had no way of telling whether those prescriptions were legitimate. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JANUARY 31, 2021
2wo: The number of mergers and acquisitions(M&A) involving one of the top 25 firms in the pharmaceutical industry more than doubled from 2006 to 2016, and the practice doesn’t seem to be abating. The cost is estimated to be in the billions.
Medico Reach
MARCH 28, 2022
The Healthcare Brand Strategy and Positioning Firm was founded in 2006, and since then, it has expanded its offices to Canada and Japan as well. These include healthcare professionals, medical executive, doctors, and every relevant person. Client Background. Its headquarter is located in New Jersey.
pharmaphorum
NOVEMBER 9, 2022
Lutz Bonacker joined CSL Behring in 2006 as Head of Global Commercial Development Coagulation and was promoted to his current position in 2015. Lutz has a Master’s Degree in Pharmacy from the Philipps-Universitaet, Marburg, Germany and a Doctorate in Microbiology/Biochemistry from Max-Planck-Institute, Marburg, Germany. References.
European Pharmaceutical Review
AUGUST 23, 2022
World Health Organization; 2006. Fake drugs kill more than 250,000 children a year, doctors warn. References. Counterfeit medicines. Available from: [link]. The Guardian. 2019; Available from: [link]. Bitter Pills: The Global War on Counterfeit Drugs: Oxford University Press; 2018.
Pharmaceutical Technology
MARCH 24, 2023
Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars. In addition, insurers’ contracting practices can help preserve the sales of brand-name drugs.
Expert insights. Personalized for you.
57 
Let's personalize your content